Objective: To investigate whether low-dose nitric oxide donor FK 409 could attenuate small-for-size graft injury in liver transplantation using small-for-size grafts. Summary Background Data: The major concern of live donor liver transplantation is small-for-size graft injury at the early phase after transplantation. Novel therapeutic strategies should be investigated. Methods: We employed a rat orthotopic liver transplantation model using small-for-size (40%) graft. FK 409 was given at 30 minutes before graft harvesting (2 mg/kg) to the donor and immediately after reperfusion (1 mg/kg) to the recipient (FK group). Graft survival, intragraft genes expression, portal hemodynamics, and hepatic ultrastructural changes were compared between the 2 groups. Results: Seven-day graft survival rates in the FK group were significantly improved compared with those of rats not receiving FK 409 (control group; 80% versus 28.6%, P ϭ 0.018). In the FK group, portal pressure was significantly decreased within the first 60 minutes after reperfusion whereas in the control group, transient portal hypertension was observed. Intragraft expression (both mRNA and protein) of early growth response-1, endothelin-1, endothelin-1 receptor A, tumor necrosis factor-␣, macrophage-inflammatory protein-2, and inducible nitric oxide synthase was significantly downregulated accompanied with up-regulation of heme oxygenase-1, A20, interferon-␥-inducible protein-10, and interleukin-10 during the first 24 hours after reperfusion. Hepatic ultrastructure, especially the integrity of sinusoids was well protected in the FK group.
T he mechanism of small-for-size graft injury after liver transplantation has been investigated recently both in animal experiments and clinical study. [1] [2] [3] [4] The degree of graft damage was inversely related to graft size in liver transplantation. Transient portal hypertension at the early phase after liver transplantation and subsequent up-regulation of vasoconstriction genes and severe inflammatory response resulted in small-for-size graft failure. Therapeutic strategies focusing on attenuation of portal hypertension together with acute phase inflammatory response have not been investigated thoroughly in liver transplantation using small-for-size grafts.
Early growth response-1 (Egr-1) is a zinc-finger transcription factor. It is a master switch coordinating up-regulation of divergent gene families related to ischemia-reperfusion injury. 5 The shear stress related to hemodynamic force resulting from transient portal hypertension can induce overexpression of Egr-1. 6 In our previous animal study, early over-expression of Egr-1 was found in small-for-size grafts after liver transplantation. 3 Nitric oxide (NO), a vaso-relaxing factor, has been demonstrated to down-regulate shear stressinduced Egr-1 expression via inhibition of the extracellular signal-regulated kinase signaling pathway. 6 Blockade of NO pathway exacerbated hepatic apoptosis and accelerated ischemia-reperfusion injury in liver transplantation. 7 FK 409, a potent NO releaser, has been demonstrated to attenuate ischemia-reperfusion injury by improving microcirculation and prior induction of heat shock proteins (Hsps) that are beneficial to intracellular homeostasis. 8 -10 A recent in vitro study also showed that FK 409 inhibited the production of endothelin-1 (ET-1), a vasoconstriction gene, which is related to sinusoidal injury and small-for-size liver graft damage. 2, 3, 11 In the present study, we aimed at investigating whether low-dose FK 409 could attenuate small-for-size graft injury in liver transplantation by studying the intragraft gene expression, portal hemodynamics and hepatic ultrastructural changes.
MATERIALS AND METHODS

Animals
Male inbred Lewis rats (180 -230 g) were used as donors and recipients. Rats were housed in a standard animal laboratory with free activity and access to water and chow. They were kept under constant environmental conditions with a 12-hour lightdark cycle. The rats were fasted 12 hours before operation. All operations were performed under clean conditions.
Surgical Procedure and Experimental Design
The experiment was conducted in 2 groups of rats: control group (n ϭ 44) and FK 409 treatment group (n ϭ 40). A rat model of nonarterialized orthotopic liver transplantation without veno-venous bypass was used as described previously. 1 The lobe ligation technique was used to reduce the graft size on the backtable. The median lobe of the liver was selected to be the graft and the median ratio of the graft weight to recipient liver weight (graft weight ratio) was 39% (range 36 -46%). The graft was stored in cold saline with a target cold ischemic time of 80 minutes.
In the FK 409 treatment group, 2 mg/kg FK 409 (kind gift from Fujisawa Pharmaceutical Co., Ltd., Japan) in 1 mL of saline was given intravenously 30 minutes before graft harvesting in the donors, and 1 mg/kg FK 409 in 1 mL of saline was given immediately after liver transplantation in the recipients. The same amount of saline was given in the control group at the same time points.
Survival Study
Ten rats in the FK group and 14 rats in the control group were used for survival study. Rats that had lived for more than 7 days after transplantation were considered survivors.
Hemodynamic Study
Six rats in each group were used for hemodynamic study. After induction of anesthesia, the right jugular vein of the recipient was cannulated with the tip of a catheter positioned at the entrance of the right atrium for monitoring of the central venous pressure. The left femoral artery and ileocolic vein were cannulated by a catheter for measurement of the mean arterial pressure and portal pressure, respectively. All catheters were connected via the pressure transducers (MLT1050 Blood Pressure, PowerLab System, ADInstruments Pty Ltd., Australia) and Quad Bridge Amp (ML118 Quad Bridge Amp, PowerLab System, ADInstruments Pty Ltd.) to a multichannel data-recording unit (ML500 PowerLab/800, PowerLab System, ADInstruments Pty Ltd.) for continuous pressure monitoring and recording. All hemodynamic data were analyzed using the PowerLab software system.
Biochemical Examination
Blood samples were collected from the recipients at 30 minutes, 2 hours, 6 hours, and 24 hours after reperfusion (6 rats for sampling at each time point) for the measurement of serum aspartate aminotransferase and total bilirubin levels (Hitachi 747 Automatic Analyzer, Boehringer Mannheim Gmbh, Mannheim, Germany).
Intragraft Gene Expression at mRNA Level by Real-Time Quantitative Reverse Transcription (RT)-Polymerase Chain Reaction (PCR)
Liver biopsies were taken from the normal livers and at 30 minutes, 2 hours, 6 hours, and 24 hours (6 rats for sampling at each time point) after reperfusion in recipients with or without FK 409 treatment. The samples were stored at Ϫ80°C until total RNA extraction. Total RNA was extracted using Rneasy Midi Kit (QIAGEN Company, GmbH, Germany) and the quality of the total RNA was detected by spectrophotometer (DU-65, Beckman Coulter, Fullerton, CA). About 1 g total RNA from each sample was used to perform RT reaction. TaqMan® Reverse Transcription Reagents (Applied Biosystems Inc., Foster City, CA) were used according to the manufacturer's instruction (25°C ϫ 10 minutes, 48°C ϫ 30 minutes, 95°C ϫ 5 minutes). RT product (1 L) was used to perform real-time quantitative PCR with a reaction volume of 50 L (TaqMan® PCR Core Reagent Kit, Applied Biosystems Inc.) by the ABI PRISM® 7700 Sequence Detection System (Applied Biosystems Inc.). Probes and primers of Egr-1, ET-1, endothelin-1 receptor A (ETA), heme oxygenase-1 (HO-1), A20 and 4 chemokines (CXCR2, IP10, CXCR3 and macrophage-inflammatory protein-2 ͓MIP-2͔) were designed under the Primer Express software according to the criteria for real-time PCR (Applied Biosystems Inc.). The sequences are listed in Table 1 . The probe and primer of tumor necrosis factor-␣ (TNF-␣) were available from Applied Biosystems. The Taqman ® Ribosomal RNA Control Reagent (18S RNA probe ͓VIC͔ and primers; Applied Biosystems Inc.) was used for internal control in the same PCR plate well to normalize the target genes amplification copies. The PCR protocol was in accordance with the manufacturer's recommendation (50°C ϫ 2 minutes, 95°C ϫ 10 minutes, ͓95°C ϫ 15 seconds, 60°C ϫ 1 minute͔ ϫ 50 cycles). All samples were detected in triplicate and the readings from each sample and its internal control were used to calculate gene expression levels. After normalization with the internal control, gene expression levels after reperfusion were calculated as the percentage of the basal levels before graft harvesting.
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Intragraft Protein Levels of Egr-1, A20, HO-1, and MIP-2 by Western Blot
Nuclear protein was extracted as described previously for detection of Egr-1 expression. Total protein was used for A20, HO-1 and MIP-2 detection. The protein samples were separated in 10% sodium dodecyl sulfate-polyacrylamide gel and electrophoretically transferred to polyvinylidene fluoride membrane (Amersham, Buckinghamshire, UK) using the Bio-Rad electrotransfer system (Bio-Rad Laboratories, Munich, Germany). The membranes were blotted with 10% skim milk, washed with Tris-buffered saline (20 mM Tris HCL, 137mM NaCl) with 0.1% Tween 20 and then probed with appropriate antibodies (Egr-1, MIP-2, actin and histone: Santa Cruz Biotechnology, Santa Cruz, CA; A20: Oncogene Research Products, San Diego, CA; HO-1: Stressgen Biotechnologies Corporation, San Diego, CA). After washing in Tris-buffered saline containing 0.1% Tween 20, the membrane was incubated with horseradish peroxidase-conjugated secondary antibody (Amersham, Little Chalfont, UK) for another 1 hour, and then visualized by enhanced chemiluminescence according to the manufacturer's recommendations (Amersham).
Intracellular Expression of ET-1, HO-1, A20, Interleukin-10 (IL-10), Inducible Nitric Oxide Synthase (iNOS), and CXCR2 by Immunostaining
The paraffin sections of the liver biopsies were immunochemically stained for ET-1, HO-1, A20, iNOS, and CXCR2 using Dako EnVision system (Dako, Glostrup, Denmark). In brief, after de-paraffinization, endogenous peroxidase activity was quenched by immersing the sections for 30 minutes in absolute methanol containing 0.3% H 2 O 2 . The sections were processed to unmask the antigens by conventional microwave oven heating in 10 mol/L citric acid buffer 
Intragraft Expression of Hsp-70 by Enzyme Immunoassay
The whole-cell protein of the liver biopsies was isolated from the liver tissues as described previously. 12 The protein expression of Hsp-70 was detected using Hsp-70 EIA kit (StressGen Biotechnologies Corp., Canada).
Apoptotic Cell Detection by TUNEL
The paraffin sections of the liver biopsies at different time points were detected for apoptosis cells by TUNEL method (In Situ Cell Death Detection Kit, Roche Biochemicals, Mannheim, Germany). 
Measurement of NO in Plasma by Chemiluminescence
Plasma was collected from each blood sample by centrifuged at 2500g for 10 minutes at 4°C and stored at Ϫ70°C until detection. Thawed samples (100 L) were diluted 4-fold with de-ionized water and de-proteinated by zinc sulfate. They were centrifuged at 10,000 g for 5 minutes at room temperature and 5 L of supernatant was injected into a chemiluminescence machine (Sievers 280 NO Analyzer, Sievers Instruments, Inc., Boulder, CO) in the same way as described previously. 13 Since NO 2 Ϫ /NO 3 Ϫ , in particular nitrate, are the end stable products of nitric oxide, this method gave a very accurate representation of NO in the blood.
Morphologic Examination
Liver biopsies were examined under electron microscopy examination. The liver biopsies were immediately cut into 1 mm cubes and fixed in 2.5% glutaraldehyde in cacodylate buffer (0.1 M sodium cacodylate-HCL buffer, pH 7.4) overnight at 4 -8°C for electron microscopy section. The specimens were examined under a transmission electron microscope (Philips EM208S, Eindhoven, Holland).
Statistical Analysis
Continuous variables were expressed as median and range. Mann-Whitney U test was used for statistical comparison. 2 test was used to compare 7-day survival rates. Significance was defined as P Ͻ 0.05. Calculations were made with the help of SPSS computer software (SPSS Inc., Chicago, IL).
RESULTS
Survival Rate
After FK409 treatment, the 7-day survival rate was improved to 80% (8/10) compared with 28.6% (4/14) in the control group (P ϭ 0.018).
Hemodynamics: Attenuation of Transient Portal Hypertension After Reperfusion
During the first hour after reperfusion, there was no significant difference in central venous pressure between the 2 groups. The mean arterial pressure was also comparable and remained stable at the early phase after liver transplantation (Fig. 1a) .
The portal pressure of the control group was at the level of 16 cmH 2 O immediately after liver transplantation and maintained at 13-17 cm H 2 O during the first hour after liver transplantation (Fig. 1b) . After FK 409 treatment, the portal pressure decreased to the basal level immediately after reperfusion and was significantly lower than that of the control group at 0, 5, 10, 30, and 60 minutes after reperfusion ( Fig. 1b) . 
Liver Function
The aspartate aminotransferase levels were significantly lower at 30 minutes and 6 hours after reperfusion in the FK group ( Fig. 2a; 30 minutes: 60.5 versus 447 U/L, P ϭ 0.014; 6 hours: 266 versus 1830 U/L, P ϭ 0.014). The total bilirubin levels were also significantly lower in the FK group than those in the control group at 30 minutes, 6 hours and 24 hours after liver transplantation ( Fig. 2b; 30 minutes: 2 versus 4 mol/L, P ϭ 0.031; 6 hours: 3 versus 6 mol/L, P ϭ 0.017; 24 hours: 2.5 versus 5 mol/L, P ϭ 0.012).
Intragraft Expression of Egr-1, ET-1, ETA, TNF-␣, MIP-2, and iNOS: Down-Regulation of Egr-1 Pathway
The intragraft mRNA levels of Egr-1 were significantly down-regulated at 30 minutes and 6 hours after reperfusion in the FK group ( Fig. 3a; 30 minutes: 77% versus 389% relative to basal level, P ϭ 0.034; 6 hours: Ϫ15% versus 258% relative to basal level, P ϭ 0.034). The intragraft protein levels of Egr-1 were consistent with the mRNA levels ( Fig. 4) .
As for ET-1 and ETA, the intragraft mRNA levels were decreased significantly at 2 hours, 6 hours, and 24 hours after liver transplantation (Fig. 3b, 3c ; ET-1, 2 hours: 33.5% versus 573% relative to basal level, P ϭ 0.034; 6 hours: Ϫ23% versus 392% relative to basal level, P ϭ 0.034; ETA, 6 hours: 157.5% versus 266% relative to basal level, P ϭ 0.021; 24 hours: 151% versus 356% relative to basal level, P ϭ 0.021). Although over-expression of intracellular ET-1 was found in both groups at 30 minutes after reperfusion ( Fig. 5a-1, 5a-3) , it decreased significantly at 24 hours after reperfusion in the FK group ( Fig. 5a-2, 5a-4) .
The intragraft mRNA levels of TNF-␣ were downregulated in the FK group at 6 hours and 24 hours after liver transplantation compared with the control group ( Fig. 3d; 6 hours: 218% versus 682% relative to basal level, P ϭ 0.038; 24 hours: 115.5% versus 609.6% relative to basal level, P ϭ 0.02). Both the intragraft mRNA level (Fig. 3e, 24 hours: 113.5% versus 672.5% relative to basal level, P ϭ 0.04) and protein level of MIP-2 ( Fig. 4) were down-regulated after FK 409 treatment.
The intracellular protein expression of iNOS was significantly down-regulated at 24 hours after liver transplantation after FK 409 treatment ( Fig. 5b-2, 5b-4 ) compared with the control group, although the comparable levels of the 2 groups were found at 30 minutes after reperfusion ( Fig. 5b-1, 5b-3 ). regulated after FK 409 treatment during the first 24 hours after reperfusion. The peak of the mRNA level of HO-1 in the FK group reached 5393% relative to basal level at 6 hours after reperfusion compared with the control group (781% relative to basal level, P ϭ 0.034) (Fig. 6a) . The intragraft protein expression of HO-1 in the FK group was found at its highest level at 24 hours after reperfusion by Western blot (Fig. 4) . The intracellular protein expression by immunostaining demonstrated that over-expression of HO-1 was mainly found in sinusoidal endothelial cells ( Fig. 7a-1, 7a-2) . On the contrary, only a few HO-1 positive endothelial cells were found at 24 hours after reperfusion accompanied with sinusoidal dilation in the control group ( Fig. 7a-3, 7a-4) . The intragraft mRNA levels of A20 were up-regulated in the FK group during the first 24 hours after reperfusion ( Fig. 6b ; 30 minutes: 769% versus Ϫ13% relative to basal level, P ϭ 0.02; 2 hours: 995% versus 121% relative to basal level, P ϭ 0.02; 6 hours: 594% versus 45% relative to basal level, P ϭ 0.02; 24 hours: 1392% versus -37% relative to basal level, P ϭ 0.02). Consistent with the mRNA expression of A20, the intracellular protein level of A20 was also found over-expressed in the FK group ( Figs. 4 and 7b) .
Intragraft protein levels of Hsp-70 were increased significantly at 24 hours after reperfusion in the FK group compared with the control group (17.7 versus 12.2 ng/ml, P ϭ 0.034).
As for the chemokines, relative higher mRNA levels of IP-10 were found in the FK group at 30 minutes and 24 hours after reperfusion ( Fig. 6c; 30 minutes: 1625% versus 115% relative to basal level, P ϭ 0.043; 24 hours: Ϫ9.5% versus Ϫ75.3% relative to basal level, P ϭ 0.021) accompanied with significant up-regulation of CXCR2 during the first 24 hours after reperfusion ( Fig. 6d; 30 minutes: 83% versus 19.3% relative to basal level, P ϭ 0.021; 2 hours: 1088% versus 72% relative to basal level, P ϭ 0.021; 6 hours: 746% versus 122.2% relative to basal level, P ϭ 0.021; 24 hours: 676.7% 
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FK409 Attenuates Small Liver Graft Injury versus 39.3% relative to basal level, P ϭ 0.021). The intracellular protein expression by immunostaining was consistent with the mRNA levels (Fig. 8a) . The intragraft protein level of IL-10 was also found over-expressed in the FK group at 24 hours after reperfusion (Fig. 8b) . There was no statistical difference in CXCR3 mRNA expression between the 2 groups during the first 24 hours after liver transplantation (Fig. 6e ).
Plasma Level of NO
In the FK 409 treatment group, the plasma levels of NO was only significantly higher than that in the control group at 30 minutes after reperfusion (61.68 ͓46.96 -65.64͔ M versus 22.34 ͓21.92 -26.24͔ M, P ϭ 0.032). At other time points, there was no statistical difference in the plasma levels of NO between the 2 groups.
Morphologic Examination Apoptosis
In the FK group, only a few apoptotic sinusoidal endothelial cells were found at 24 hours after liver transplantation compared with the control group (Fig. 9a ).
Electron Microscopy
In the FK treatment group, hepatocytes and sinusoidal cells had normal appearance at 30 minutes, 2 hours, 6 hours ( Fig. 9b-1 ), and 24 hours ( Fig. 9b-2 ) after liver transplantation. Chromatin in the nucleus appeared normal. Mitochondria were elliptical, with well-visualized cristae. The endoplasmic reticulum was intact, and there were abundant microvilli in the space of Disse. The sinusoidal lining cells were intact.
In the control group, mitochondrial swelling of hepatocytes was present at 2 hours after reperfusion and deteriorated at 6 hours ( Fig. 9b-3 ) after liver transplantation accompanied with the irregular large gap of sinusoidal lining cells and loss of microvilli in the space of Disse. Twenty-four hours after reperfusion ( Fig. 9b-4) , the integrity of endothelial cells was disrupted.
DISCUSSION
Up-regulation of vasoconstrictive genes that induced sinusoidal injury accompanied with severe acute inflammatory response at the early phase after reperfusion is probably the main cause of small-for-size graft damage after liver transplantation. 1, 2 The shear stress resulting from transient portal hypertension at the early phase after liver transplantation played a critical role in the up-regulation of Egr-1, which is the master switcher of ischemia-reperfusion injury. 5, 6 NO has been demonstrated not only to regulate Egr-1 expression induced by shear stress, 6 but also to attenuate ischemiareperfusion injury through its antiapoptotic effect. 14 To attenuate the transient portal hypertension resulting from sinu-soidal constriction and excessive hepatic blood flow relative to small grafts, a vaso-dilator seems to be an ideal treatment at the acute phase after reperfusion. FK 409, being a NO donor and vasodilator has been shown to improve hepatic microcirculation in the ischemia-reperfusion model when administrated during the reperfusion period. 15 However, because it could induce several Hsps, such as HO-1 and Hsp-70, in the graft prior to harvesting, 8 pretreatment in the donor also seems to be very important. Therefore, in the present study, we used FK 409 30 minutes before graft harvesting in the donor and immediately after reperfusion in the recipient of small-for-size grafts. The results appear promising. The major concern of this NO releaser is the possible effect on systemic hemodynamics when it is used in a relatively high dose. 9 The lower mean arterial blood pressure at the early phase after liver transplantation was found in the rats implanted with less than 30% grafts and was related to a higher mortality in our previous animal study. 1 In the present study, we applied a low dose of FK 409 that could induce a significant plasma level of NO during the first 30 minutes after reperfusion without any influence on the systemic arterial blood pressure. At such level of NO, the portal pressure decreased significantly and was back to the basal level quickly compared with the rats in the control group during the first hour after reperfusion. Attenuation of shear stress induced by hemodynamic force ameliorated the acute phase inflammatory response by down-regulation of Egr-1 and its downstream genes, such as ET-1, ETA, iNOS, MIP-2, and TNF-␣. Extinguishing Egr-1-dependent inflammatory response could significantly improve the graft function and recipient survival after lung transplantation in a rat model. 16 ET-1 was considered to be a vasoconstriction factor leading to direct sinusoidal constriction, hepatic blood flow disruption and increase in intrahepatic resistance. [17] [18] [19] The overexpression of ET-1 played a critical role in small-for-size graft failure after liver transplantation. 4 In the present study, the significant down-regulation of ET-1 and its receptor ETA, which is the major receptor responsible for vasoconstrictive activity, ameliorated the sinusoidal constriction, 20 then improved the hepatic microcirculation. Not only were the vasoconstrictive genes down-regulated by FK 409 treatment, the inflammatory cytokine and chemokine such as iNOS, 21, 22 TNF-␣, and MIP-2, 23 were also down-regulated at protein or mRNA levels. The anti-inflammatory cytokine IL-10, 24 which has been shown to prevent hepatic ischemia-reperfusion injury by suppressing nuclear factor B activation, was up-regulated after FK409 treatment. The hepatic protective chemokine IP-10 was over-expressed. Together with CXCR2, they were important for hepatoregenerative function during acute liver injury model. 25 The over-expression of 2 Hsps, HO-1 and Hsp-70, which are important for the maintenance of intracellular homeostasis and vasodilation, 12, 26, 27 was found in the FK treatment group together with the antiapoptotic gene A20. 28, 29 These distinct intragraft gene expression profiles in the FK treatment group were consistent with the better preservation of liver function and significant improvement of the 7-day survival. The sinusoidal endothelial cells were protected from apoptosis, which was considered as a critical mechanism of graft injury in liver transplantation. 30 The maintenance of the integrity of sinusoids by FK 409 treatment was also very important for hepatic microcirculation. 1, 2 The normal mitochondrial ultrastructure compared with the tre- FK409 Attenuates Small Liver Graft Injury mendous swelling of mitochondria in the control group probably contributed to the preservation of liver function. 31 In summary, the mechanical injury of hepatic sinusoids related to transient portal hypertension as well as acute phase inflammatory response probably contributed to graft damage in small-for-size graft at the early phase after liver transplantation. The present study has demonstrated the first evidence in vivo that FK 409 could attenuate transient portal hypertension together with down-regulation of Egr-1 and prior induction of anti-inflammatory cytokine and Hsps after liver transplantation using small-for-size grafts. The possible mechanism of rescue of small-for-size liver grafts by FK 409 (Fig. 10 ) illustrated by this study showed its potential clinical application not only in the attenuation of small-for-size graft damage in the recipients, but also in the prevention of small liver remnant injury in the donors after living graft donation.
